BioVie Inc. Proceeds from Notes Payable
BioVie Inc. (BIVI) reported Proceeds from Notes Payable of $14.61 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-05-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2023-08-16
- BioVie Inc. proceeds from notes payable for the quarter ending 2022-06-30 was $0.00.
- BioVie Inc. proceeds from notes payable for the quarter ending 2022-03-31 was $0.00.
- BioVie Inc. proceeds from notes payable for the quarter ending 2017-12-31 was -$10.00K, a 500.00% decline year-over-year.
- BioVie Inc. proceeds from notes payable for the quarter ending 2017-09-30 was -$25.00K, a 412.50% decline year-over-year.
- BioVie Inc. proceeds from notes payable for fiscal 2022 was $14.61M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2022-09-30 | $14.61M 10-Q · filed 2022-05-11 | |||
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-16 | $0.00 derived: sum of 2 quarters · filed 2023-08-16 | $14.61M 10-K · filed 2023-08-16 | |
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-12 | $14.61M 10-Q · filed 2023-05-12 | ||
| 2021-12-31 | $14.61M 10-Q · filed 2023-02-10 | |||
| 2017-12-31 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | -$35.00K 10-Q · filed 2018-02-14 | ||
| 2017-09-30 | -$25.00K 10-Q · filed 2017-11-08 | |||
| 2016-12-31 | $2.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | $10.50K 10-Q · filed 2018-02-14 | ||
| 2016-09-30 | $8.00K 10-Q · filed 2017-11-08 | |||
| 2015-09-30 | $0.00 10-Q/A · filed 2017-01-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |